Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China · Delayed Price · Currency is CNY 22.02
-1.61 (-6.81%)
Oct 30, 2026, 3:04 PM CST
SHE:002317 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 857.55 | 985.4 | 1,399 | 1,252 | 927.67 | 1,016 |
Short-Term Investments | - | 221.38 | 163.69 | 389.1 | 151.75 | 40 |
Trading Asset Securities | 461.72 | 103.66 | 305.99 | 683.06 | 340.68 | 239.92 |
Cash & Short-Term Investments | 1,319 | 1,310 | 1,869 | 2,324 | 1,420 | 1,296 |
Cash Growth | -4.55% | -29.89% | -19.58% | 63.66% | 9.55% | -20.49% |
Accounts Receivable | 898.78 | 1,222 | 999.6 | 978.3 | 1,204 | 792.46 |
Other Receivables | 6.63 | 49.48 | 55.85 | 45.62 | 29.44 | 11.48 |
Receivables | 905.41 | 1,271 | 1,055 | 1,024 | 1,233 | 803.94 |
Inventory | 402.71 | 365.3 | 441.48 | 520.39 | 481.06 | 452.2 |
Prepaid Expenses | - | - | - | - | - | 0 |
Other Current Assets | 525.76 | 96.49 | 96.74 | 92.1 | 100.4 | 119.12 |
Total Current Assets | 3,153 | 3,044 | 3,463 | 3,961 | 3,235 | 2,672 |
Property, Plant & Equipment | 768.88 | 802.14 | 687.36 | 695.91 | 636.82 | 601.24 |
Long-Term Investments | 137.04 | 299.33 | 516.23 | 519.95 | 727.09 | 650.61 |
Goodwill | 6.95 | 6.95 | 6.95 | 208.63 | 208.63 | 208.63 |
Other Intangible Assets | 477.32 | 503.71 | 327.11 | 446.7 | 260.4 | 261.28 |
Long-Term Deferred Tax Assets | 16.19 | 20.57 | 29.69 | 42.45 | 47.03 | 46.89 |
Long-Term Deferred Charges | 519.86 | 435.2 | 489.91 | 564.31 | 586.61 | 401.03 |
Other Long-Term Assets | 49.19 | 18 | 33.44 | 19.97 | 74.15 | 60.76 |
Total Assets | 5,129 | 5,130 | 5,553 | 6,459 | 5,775 | 4,902 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 91.5 | 117.96 | 93.1 | 93.78 | 126.28 | 106.7 |
Accrued Expenses | 17.08 | 165.76 | 141.86 | 163.32 | 232.01 | 164.43 |
Short-Term Debt | 219.69 | 318.52 | 303.46 | 621.49 | 587.6 | 190 |
Current Portion of Long-Term Debt | 13.52 | - | - | 2.09 | 22 | 12 |
Current Portion of Leases | - | 1.74 | 1.66 | 2.72 | 2.55 | 1.71 |
Current Income Taxes Payable | 28.84 | 2.81 | 4.92 | 12.46 | 13.61 | 1.51 |
Current Unearned Revenue | 220.65 | 20.6 | 20.08 | 25.91 | 45.24 | 18.85 |
Other Current Liabilities | 133.47 | 90.93 | 638.39 | 93.54 | 79.04 | 29 |
Total Current Liabilities | 724.75 | 718.32 | 1,203 | 1,015 | 1,108 | 524.2 |
Long-Term Debt | - | - | - | 97 | 286 | 308 |
Long-Term Leases | 4.66 | 6.04 | 0.3 | 1.3 | 4.02 | 5.27 |
Long-Term Unearned Revenue | 187.87 | 202.05 | 161.94 | 132.67 | 55.57 | 32.74 |
Long-Term Deferred Tax Liabilities | 44.79 | 41.27 | 38.9 | 48.95 | 70.23 | 59.96 |
Other Long-Term Liabilities | - | 12.03 | 138.76 | 637.61 | 434.68 | 433.67 |
Total Liabilities | 962.07 | 979.71 | 1,543 | 1,933 | 1,959 | 1,364 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 849.93 | 849.93 | 851.56 | 853.35 | 814.43 | 814.46 |
Additional Paid-In Capital | 1,826 | 1,816 | 1,780 | 1,807 | 1,310 | 1,321 |
Retained Earnings | 1,349 | 1,342 | 1,237 | 1,706 | 1,604 | 1,444 |
Treasury Stock | - | - | -8.1 | -67.14 | -80.36 | -151.6 |
Comprehensive Income & Other | 46.97 | 49.51 | 54.86 | 57.36 | 54.45 | 47.52 |
Total Common Equity | 4,072 | 4,058 | 3,915 | 4,356 | 3,703 | 3,476 |
Minority Interest | 94.2 | 91.68 | 95.34 | 169.37 | 113.72 | 62.49 |
Shareholders' Equity | 4,167 | 4,150 | 4,010 | 4,526 | 3,816 | 3,538 |
Total Liabilities & Equity | 5,129 | 5,130 | 5,553 | 6,459 | 5,775 | 4,902 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 237.86 | 326.3 | 305.43 | 724.6 | 902.17 | 516.98 |
Net Cash (Debt) | 1,081 | 984.14 | 1,564 | 1,600 | 517.93 | 779.3 |
Net Cash Growth | 27.85% | -37.06% | -2.24% | 208.85% | -33.54% | -14.76% |
Net Cash Per Share | 1.29 | 1.18 | 1.88 | 1.94 | 0.64 | 0.98 |
Filing Date Shares Outstanding | 808.37 | 849.93 | 846.01 | 847.8 | 808.88 | 797.43 |
Total Common Shares Outstanding | 808.37 | 849.93 | 846.01 | 847.8 | 808.88 | 797.43 |
Working Capital | 2,428 | 2,325 | 2,259 | 2,945 | 2,126 | 2,147 |
Book Value Per Share | 5.04 | 4.77 | 4.63 | 5.14 | 4.58 | 4.36 |
Tangible Book Value | 3,588 | 3,548 | 3,581 | 3,701 | 3,234 | 3,006 |
Tangible Book Value Per Share | 4.44 | 4.17 | 4.23 | 4.37 | 4.00 | 3.77 |
Buildings | - | 573.53 | 561.69 | 527.39 | 506.28 | 474.51 |
Machinery | - | 763.36 | 734.13 | 638.4 | 600.95 | 568.8 |
Construction In Progress | - | 151.31 | 27.58 | 123.55 | 82.03 | 56.47 |